November 2024

Press Release

Notice of Meeting and Record Date Nov Dec 2024

2.181215277777778 days ago Nov 15, 2024

November 5, 2024 Filed via SEDAR+ To All Applicable Exchanges and Securities Administrators Subject: RepliCel...

Press Release

Preferred Share Conversion

2.181215277777778 days ago Nov 15, 2024

RepliCel Life Sciences Announces Intention to complete Preferred Share Conversion and Settlement of DividendsVANCOUVER, BC...

by Type

by Topic

by month

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.